Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review

[1]  M. Rowbotham,et al.  A snapshot and scorecard for analgesic clinical trials for chronic pain: The RReACT database , 2012, PAIN®.

[2]  John A. Cornell,et al.  Statistical Methods (7th ed.) , 2012 .

[3]  A. Marson,et al.  Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms , 2011, Epilepsy Research.

[4]  D. Moher,et al.  An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials , 2011, BMC complementary and alternative medicine.

[5]  W. Rief,et al.  Assessing general side effects in clinical trials: reference data from the general population , 2011, Pharmacoepidemiology and drug safety.

[6]  Douglas G Altman,et al.  Use of the Internet by print medical journals in 2003 to 2009: a longitudinal observational study. , 2011, Annals of emergency medicine.

[7]  I. Tirodimos,et al.  The quality of safety reporting in trials is still suboptimal: survey of major general medical journals. , 2011, Journal of clinical epidemiology.

[8]  E. Roon,et al.  Low quality of reporting adverse drug reactions in paediatric randomised controlled trials , 2010, Archives of Disease in Childhood.

[9]  E. V. van Roon,et al.  Low quality of reporting adverse drug reactions in paediatric randomised controlled trials , 2010, Archives of Disease in Childhood.

[10]  Richard E. White,et al.  Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations , 2010, PAIN®.

[11]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.

[12]  D. Moher,et al.  coNSorT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2020 .

[13]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[14]  Ethan Basch,et al.  The missing voice of patients in drug-safety reporting. , 2010, The New England journal of medicine.

[15]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[16]  John P A Ioannidis,et al.  Adverse events in randomized trials: neglected, restricted, distorted, and silenced. , 2009, Archives of internal medicine.

[17]  Isabelle Boutron,et al.  Reporting of safety results in published reports of randomized controlled trials. , 2009, Archives of internal medicine.

[18]  P. Dahm,et al.  Reporting of harm in randomized controlled trials published in the urological literature. , 2009, The Journal of urology.

[19]  P. Masand,et al.  The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. , 2009, Contemporary clinical trials.

[20]  Robert L Kane,et al.  Reporting in randomized clinical trials improved after adoption of the CONSORT statement. , 2007, Journal of clinical epidemiology.

[21]  D. Moher,et al.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.

[22]  S. Goodman,et al.  Adverse Events: The More You Search, the More You Find , 2006, Annals of Internal Medicine.

[23]  P. Tugwell,et al.  Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials. , 2005, Journal of clinical epidemiology.

[24]  Joel Gagnier,et al.  The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. , 2005, Contemporary clinical trials.

[25]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[26]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[27]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[28]  J. Farrar,et al.  Core outcome domains for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[29]  Gordon H Guyatt,et al.  The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. , 2002, Controlled clinical trials.

[30]  D. Moher,et al.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. , 2001, JAMA.

[31]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.

[32]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[33]  R. Moore,et al.  Reporting of adverse effects in clinical trials should be improved: lessons from acute postoperative pain. , 1999, Journal of pain and symptom management.

[34]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[35]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[36]  Alec B. O’Connor.  Neuropathic Pain , 2012, PharmacoEconomics.

[37]  S. Hofmann,et al.  Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials , 2009, Drug safety.

[38]  R. Bausell,et al.  Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). , 2008, Nursing outlook.